Indo US Bio-Tech Ltd
Food, Beverages & Tobacco | Small Cap
Indo US Bio-Tech Ltd, operating in the FMCG sector, demonstrates a mixed financial performance. The company showcases strong profitability with healthy margins and returns on capital and equity. However, its liquidity position is weak, indicating potential challenges in meeting short-term obligations. The company's growth rates are also concerning, showing negative trends in revenue, operating profit, and earnings per share. While the company maintains a reasonable solvency position, its efficiency in utilizing assets is low. The ability to cover interest and dividends is also limited. The financial ratios reflect low earnings per share and book value, but capital expenditures are well-managed. Overall, the company needs to address its liquidity and growth challenges while leveraging its profitability strengths for sustainable financial health.
Latest Report
View AllLatest News
View AllThe Latest News Is Not Available at the Moment. We’ll Notify You Once It’s Available.
- Valuation MetricsHighly Overvalued
- Market Metrics
- Stock Reports
- Stock News
- Growth Ratio2.00
- Financial Ratio4.00
- Profitability Ratio9.20
- Efficiency Ratio4.67
- Coverage Ratio2.00
- Solvency Ratio8.00
- Liquidity Ratio2.00
- Peer Assessment
- Management AssessmentBalanced
- Risk AssessmentBalanced
- 1 HourBearish
- 2 HoursNeutral
- 4 HoursNeutral
- 1 DayBearish
- 1 WeekBearish
- 1 MonthNeutral
Indo US Bio-Tech Ltd, operating in the FMCG sector, demonstrates a mixed financial performance. The company showcases strong profitability with healthy margins and returns on capital and equity. However, its liquidity position is weak, indicating potential challenges in meeting short-term obligations. The company's growth rates are also concerning, showing negative trends in revenue, operating profit, and earnings per share. While the company maintains a reasonable solvency position, its efficiency in utilizing assets is low. The ability to cover interest and dividends is also limited. The financial ratios reflect low earnings per share and book value, but capital expenditures are well-managed. Overall, the company needs to address its liquidity and growth challenges while leveraging its profitability strengths for sustainable financial health.
Latest Report
View AllLatest News
View AllThe Latest News Is Not Available at the Moment. We’ll Notify You Once It’s Available.
Overall Valuation Score
P/E RATIO (TTM)
13.93
Industry Median
16.94
Small Cap Median
16.94
P/E RATIO
32.93
P/B RATIO
4.34
Industry Median
1.97
Small Cap Median
1.97
P/S RATIO
3.97
Industry Median
1.29
Small Cap Median
1.29
Others
PEG RATIO
0.79
EV/EBITDA RATIO
28.66
The Calculations Shown Above Are Based on the Last Traded Price (LTP) of ₹91.21 as on Jun 19, 2026.
Unlock Live Chart
Please login to view interactive real-time technical charts powered by TradingView.
Markets Depth NSE
Buy Orders
Bid
Quantity
Orders
No buy depth
Total
0
0
Sell Orders
Ask
Quantity
Orders
No sell depth
Total
0
0
Markets Today NSE
High
0.00
Low
0.00
Open
0.00
Close
0.00
Prev Close
0.00
Avg Price
0.00
Volume
0
Last Traded Quantity
0
Last Traded Time
N/A
Price Movement Indicator
0.00
Today's Low
0.00
Today's High
Quarterly Report⬤21st Jan 26
Quarterly Financial Results Q3 FY 2025–26
BEARISH SENTIMENT
The growth rates show significant negative trends across revenue, operating profit, earnings per share, assets, and net income. This indicates potential challenges in the company's ability to expand and sustain its operations. Addressing these issues is crucial for revitalizing growth and ensuring long-term success.
| Growth Ratios | Mar 2020 | Mar 2021 | Mar 2022 |
|---|---|---|---|
| Revenue Growth Rate | -0.93 | 25.39 | |
| Operating Profit Growth Rate | 34.42 | 26.92 | |
| Earnings Per Share (EPS) Growth | 94.25 | -18.05 | |
| Asset Growth Rate | 25.97 | 27.25 | |
| Net Income Growth Rate | 93.68 | 3.27 |
Revenue Growth Rate
Operating Profit Growth Rate
Earnings Per Share (EPS) Growth
Asset Growth Rate
Net Income Growth Rate
The components for financial health present a mixed view. Low adjusted and cash earnings per share, along with a low book value per share, raise concerns about profitability and shareholder value. However, well-managed capital expenditures indicate prudent financial management. Improving earnings and book value is essential for enhancing overall financial health.
| Financial Ratios | Mar 2020 | Mar 2021 | Mar 2022 |
|---|---|---|---|
| Adjusted Earnings Per Share (Adjusted EPS) | 4.16 | 8.05 | 5.5 |
| Cash Earnings Per Share (Cash EPS) | 4.52 | 8.48 | 6 |
| Book Value Per Share | 26.95 | 34.98 | 41.86 |
| Dividend Per Share (DPS) | 0 | 0 | 0 |
| Capital Expenditures (CapEx) | 0.4 | 1.9 | 4 |
Adjusted Earnings Per Share (Adjusted EPS)
Cash Earnings Per Share (Cash EPS)
Book Value Per Share
Dividend Per Share (DPS)
Capital Expenditures (CapEx)
The components for profitability showcase strong performance. Very high gross profit, return on capital employed, return on equity, operating margin, and net margin indicate efficient operations and effective cost management. However, a low return on assets suggests there might be room to improve asset utilization to further boost profitability.
| Profitability Ratios | Mar 2020 | Mar 2021 | Mar 2022 |
|---|---|---|---|
| Gross Profit Margin | 9.43 | 12.9 | 12.82 |
| Return on Capital Employed (ROCE) | 20.84 | 17.68 | 15.45 |
| Return on Equity (ROE) | 15.39 | 22.96 | 13.14 |
| Return on Assets (ROA) | 11.47 | 12.24 | 12.21 |
| Operating Margin | 10.01 | 13.58 | 13.75 |
| Net Margin | 6.36 | 12.44 | 10.24 |
Gross Profit Margin
Return on Capital Employed (ROCE)
Return on Equity (ROE)
Return on Assets (ROA)
Operating Margin
Net Margin
The efficiency ratio reveals a mixed performance. While days sales in inventory and receivable days are well-managed, very low turnover ratios for fixed assets, inventory, receivables, and capital indicate underutilization of assets. This may result in lost revenue opportunities. Optimizing asset utilization can lead to improved profitability and operational performance.
| Efficiency Ratios | Mar 2020 | Mar 2021 | Mar 2022 |
|---|---|---|---|
| Fixed Asset Turnover Ratio | 28.2 | 16.62 | 8.9 |
| Inventory Turnover Ratio | 3.94 | 3.26 | 2.44 |
| Receivables Turnover Ratio | 1.9 | 1.72 | 2.18 |
| Days Sales in Inventory Ratio | 92.64 | 111.96 | 149.59 |
| Receivable Days | 192.6 | 212.21 | 167.43 |
| Capital Turnover Ratio | 2.22 | 1.59 | 1.17 |
Fixed Asset Turnover Ratio
Inventory Turnover Ratio
Receivables Turnover Ratio
Days Sales in Inventory Ratio
Receivable Days
Capital Turnover Ratio
The components for coverage reveal potential challenges in meeting financial obligations. Both interest coverage and equity dividend coverage are very low, suggesting the company may struggle to cover interest expenses and provide dividends to shareholders. Improving these ratios is essential for maintaining financial stability and investor confidence.
| Coverage Ratios | Mar 2020 | Mar 2021 | Mar 2022 |
|---|---|---|---|
| Interest Coverage Ratio | 4.25 | 4.33 | 5.42 |
| Equity Dividend Coverage Ratio |
Interest Coverage Ratio
Equity Dividend Coverage Ratio
The components for solvency demonstrate a mixed scenario. While manageable debt levels and prudent debt-to-asset management suggest a good position, very low equity levels raise concerns about long-term financial stability. This situation may limit the company's capacity to withstand financial challenges. Balancing debt and equity is essential to ensure sustainable financial health and resilience.
| Solvency Ratios | Mar 2020 | Mar 2021 | Mar 2022 |
|---|---|---|---|
| Debt Ratio | 0.08 | 0.14 | 0.09 |
| Debt to Equity Ratio | 0.09 | 0.16 | 0.1 |
| Equity Ratio | 0.92 | 0.86 | 0.91 |
| Debt To Asset Ratio | 0.04 | 0.08 | 0.07 |
Debt Ratio
Debt to Equity Ratio
Equity Ratio
Debt To Asset Ratio
The liquidity position reflects that the company may face difficulties in meeting its short-term obligations. Low current, quick, and cash ratios indicate a struggle to convert assets into cash quickly. Although operating cash flow could help, the overall picture suggests potential issues in managing day-to-day financial needs. Without sufficient liquid assets, the company might need to seek external financing or delay payments, affecting its operational efficiency and relationships with suppliers.
| Liquidity Ratios | Mar 2020 | Mar 2021 | Mar 2022 |
|---|---|---|---|
| Current Ratio | 1.91 | 2.08 | 3.57 |
| Quick Ratio | 1.36 | 1.45 | 1.82 |
| Cash Ratio | 0.01 | 0.01 | 0 |
| Operating Cash Flow Ratio | -0.05 | 0.01 | 0.2 |
Current Ratio
Quick Ratio
Cash Ratio
Operating Cash Flow Ratio
Peer Comparison empowers investors to evaluate a company against its industry peers using key financial metrics like P/E ratio, EPS, and profit margins. It helps identify whether a company is overvalued, undervalued, or performing in line with competitors. Investors can use this data to spot opportunities, assess risks, and make informed decisions. This contextual view adds depth beyond standalone company analysis.
| NO | Company Name | Health Score | P/E Ratio | Valuation | OPM | EPS | Latest Profit & Loss |
|---|---|---|---|---|---|---|---|
| 1 | Jeyyam Global Foods Ltd | 8.14 | 7.97 | Neutral | 30.00 | 2.89 | 14.00 |
| 2 | Sheetal Universal Ltd | 7.88 | 28.86 | Neutral | 21.00 | 10.05 | 12.00 |
| 3 | Upsurge Seeds of Agriculture Ltd | 7.34 | 14.01 | Neutral | 14.00 | 7.42 | 7.00 |
| 4 | Shreeoswal Seeds & Chemicals Ltd | 6.94 | 33.38 | Overvalued | 15.00 | 0.32 | 7.00 |
| 5 | Indo US Bio-Tech Ltd | 5.37 | 32.93 | Highly Overvalued | 6.79 | 6.55 | 5.06 |
| 6 | Nath Bio-Genes (India) Ltd | 4.76 | 7.34 | Neutral | 52.00 | 23.38 | 42.00 |
| 7 | TBI Corn Ltd | 4.72 | 6.47 | Neutral | 35.00 | 10.11 | 19.00 |
| 8 | KCK Industries Ltd | 4.67 | 207.27 | Neutral | 0.02 | 0.07 | 0.42 |
The management effectiveness of Indo US Bio-Tech Ltd shows a mixed performance. The company has achieved notable sales growth and maintains a reasonable level of profitability. However, there are concerns regarding the high P/E ratio relative to its peers and negative cash flow from operations. Despite these challenges, the significant promoter holding suggests ongoing confidence in the company's future.
| Category | Metric | Value | Assessment |
|---|---|---|---|
| PROS | Sales Growth | 25% | Strong sales growth demonstrated |
| Promoter Holding | 70.18% | Indicates confidence and alignment | |
| CONS | P/E Ratio | 62.8 | Comparatively high P/E ratio |
| Cash Conversion Cycle | Inconsistent | Inefficient working capital management |
Financial Performance & Growth
Indo US Bio-Tech's financial performance indicates positive but inconsistent growth. Sales Growth TTM is strong at 25%. Compounded Profit Growth TTM is 3%. The Operating Profit Margin (OPM) has improved:
| Metric | Mar 2020 | Mar 2021 | Mar 2022 |
|---|---|---|---|
| OPM % | 10.01% | 13.58% | 13.75% |
Net Profit increased from 2.53 Cr in Mar 2020 to 5.06 Cr in Mar 2022. Overall, sales growth is robust, the slower profit growth merits an 'Average' rating.
Capital Efficiency & Returns
The capital efficiency of Indo US Bio-Tech is mixed. The Return on Equity (ROE) for the last year is 17%. The ROCE % is at 15.45% (Mar 2022). The Cash Conversion Cycle (CCC) has been volatile:
| Metric | Mar 2020 | Mar 2021 | Mar 2022 |
|---|---|---|---|
| Cash Conversion Cycle | 276.26 | 228.97 | 151.87 |
The declining CCC over the period suggests improving efficiency, but the high initial values indicate potential for further optimization. Overall, the capital efficiency and returns are rated as 'Average'.
Financial Health & Prudence
Indo US Bio-Tech's financial health presents a mixed assessment. The company has borrowings, with total borrowings increasing from 8.58 Cr in Mar 2020 to 12.84 Cr in Mar 2022. Interest coverage, calculated as Operating Profit / Interest, is as follows:
| Metric | Mar 2020 | Mar 2021 | Mar 2022 |
|---|---|---|---|
| Operating Profit / Interest | 4.52 | 4.53 | 5.66 |
Shareholding & Ownership Structure
The shareholding pattern of Indo US Bio-Tech indicates stable promoter confidence. Promoters hold a significant portion of the company's shares. The promoter holding is around 70.18% (Mar 2025). This high level of promoter holding suggests a strong alignment of interests between the management and the shareholders.
The risk assessment for Indo US Bio-Tech is rated as 'Orange' due to a combination of factors. While the company exhibits strong promoter holding and sales growth, there are notable concerns regarding working capital management, as indicated by inconsistent cash conversion cycles. Additionally, the relatively high P/E ratio compared to peers suggests potential overvaluation.
Off-balance sheet exposure quantification
There is no data available for Off-balance sheet exposure quantification.
Contingent liability evaluation
There is no data available for Contingent liability evaluation.
Accounting quality red flags
There is no data available for Accounting quality red flags.
Segment performance volatility
There is no data available for Segment performance volatility.
0 Credits RemainingUnlock Deep Technical Insights in Seconds Only with Dhanarthi AI
Overall Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bearish
Market Sentiment
Analysis Driven By 26 Technical Indicators From The 1 Hour Timeframe
Trend Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bearish
Momentum Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Volatility Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bearish
Volume Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
- IndicatorValueSignal
- SMA 1091.24Bearish
- SMA 2090.91Bearish
- SMA 5090.54Bearish
- EMA 1091.08Bearish
- EMA 2090.98Bearish
- EMA 5091.60Bearish
- DEMA 1091.13Bearish
- DEMA 2091.08Bearish
- DEMA 5089.75Bullish
- TEMA 1090.94Bearish
- TEMA 2091.44Bearish
- TEMA 5090.43Bullish
- MACD0.08Bullish
- ADX24.31Weak Trend
- IndicatorValueSignal
- RSI47.85Neutral
- CCI14.28Neutral
- ROC 90.58Bullish
- ROC 14-0.01Bearish
- ROC 251.23Bullish
- Stoch K34.45Neutral
- Stoch D39.76Neutral
- IndicatorValueSignal
- BB Upper93.23Neutral
- BB Middle90.91Neutral
- BB Lower88.60Neutral
- ATR1.70High Volatility
- IndicatorValueSignal
- MFI38.45Neutral
Overall Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Market Sentiment
Analysis Driven By 26 Technical Indicators From The 2 Hours Timeframe
Trend Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bearish
Momentum Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Volatility Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Volume Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
- IndicatorValueSignal
- SMA 1090.93Bearish
- SMA 2090.57Bearish
- SMA 5093.05Bearish
- EMA 1090.88Bearish
- EMA 2091.01Bearish
- EMA 5093.03Bearish
- DEMA 1091.00Bearish
- DEMA 2090.27Bullish
- DEMA 5089.37Bullish
- TEMA 1091.11Bearish
- TEMA 2091.05Bearish
- TEMA 5089.08Bullish
- MACD-0.45Bullish
- ADX24.07Weak Trend
- IndicatorValueSignal
- RSI47.34Neutral
- CCI45.30Neutral
- ROC 90.57Bullish
- ROC 140.71Bullish
- ROC 251.11Bullish
- Stoch K38.81Neutral
- Stoch D47.07Neutral
- IndicatorValueSignal
- BB Upper92.84Neutral
- BB Middle90.57Neutral
- BB Lower88.29Neutral
- ATR2.41Low Volatility
- IndicatorValueSignal
- MFI69.88Neutral
Overall Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Market Sentiment
Analysis Driven By 26 Technical Indicators From The 4 Hours Timeframe
Trend Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bearish
Momentum Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Volatility Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Volume Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
- IndicatorValueSignal
- SMA 1090.60Bearish
- SMA 2091.81Bearish
- SMA 5096.99Bearish
- EMA 1091.16Bearish
- EMA 2092.28Bearish
- EMA 5096.06Bearish
- DEMA 1090.67Bearish
- DEMA 2089.60Bullish
- DEMA 5091.29Bearish
- TEMA 1091.47Bearish
- TEMA 2089.97Bullish
- TEMA 50N/AN/A
- MACD-1.84Bullish
- ADX28.78Strong Trend
- IndicatorValueSignal
- RSI41.76Neutral
- CCI-36.09Neutral
- ROC 90.54Bullish
- ROC 140.60Bullish
- ROC 25-7.01Bearish
- Stoch K48.72Neutral
- Stoch D42.67Neutral
- IndicatorValueSignal
- BB Upper97.15Neutral
- BB Middle91.81Neutral
- BB Lower86.48Neutral
- ATR3.51Low Volatility
- IndicatorValueSignal
- MFI40.97Neutral
Overall Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bearish
Market Sentiment
Analysis Driven By 33 Technical Indicators From The 1 Day Timeframe
Trend Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bearish
Momentum Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Volatility Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bearish
Volume Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
- IndicatorValueSignal
- SMA 1092.11Bearish
- SMA 2095.81Bearish
- SMA 50102.01Bearish
- SMA 100111.62Bearish
- SMA 200121.44Bearish
- EMA 1092.01Bearish
- EMA 2095.11Bearish
- EMA 50101.22Bearish
- EMA 100108.95Bearish
- EMA 200125.90Bearish
- DEMA 1088.85Bullish
- DEMA 2090.08Bearish
- DEMA 5092.77Bearish
- DEMA 10094.39Bearish
- DEMA 20090.82Bearish
- TEMA 1088.68Bullish
- TEMA 2088.66Bullish
- TEMA 5091.29Bearish
- TEMA 10094.45Bearish
- TEMA 200N/AN/A
- MACD-3.87Bearish
- ADX30.20Strong Trend
- IndicatorValueSignal
- RSI29.24Oversold
- CCI-91.23Neutral
- ROC 14-10.16Bearish
- ROC 25-15.48Bearish
- Stoch K11.56Oversold
- Stoch D10.94Oversold
- IndicatorValueSignal
- BB Upper104.69Neutral
- BB Middle95.81Neutral
- BB Lower86.94Neutral
- ATR5.10High Volatility
- IndicatorValueSignal
- MFI42.59Neutral
Overall Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bearish
Market Sentiment
Analysis Driven By 21 Technical Indicators From The 1 Week Timeframe
Trend Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Strong Bearish
Momentum Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Volatility Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Volume Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
- IndicatorValueSignal
- SMA 20111.15Bearish
- SMA 50128.30Bearish
- EMA 20108.71Bearish
- EMA 50132.94Bearish
- DEMA 2096.04Bearish
- DEMA 50N/AN/A
- TEMA 2096.24Bearish
- TEMA 50N/AN/A
- MACD-9.58Bearish
- ADX10.96Weak Trend
- IndicatorValueSignal
- RSI37.04Neutral
- CCI-141.09Oversold
- ROC 14-21.38Bearish
- ROC 25-27.70Bearish
- Stoch K5.35Oversold
- Stoch D7.43Oversold
- IndicatorValueSignal
- BB Upper142.17Neutral
- BB Middle111.15Neutral
- BB Lower80.14Neutral
- ATR13.10Low Volatility
- IndicatorValueSignal
- MFI43.36Neutral
Overall Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Market Sentiment
Analysis Driven By 25 Technical Indicators From The 1 Month Timeframe
Trend Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bearish
Momentum Score
No results for this timeframe
Volatility Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Volume Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
- IndicatorValueSignal
- SMA 6115.60Bearish
- SMA 12131.08Bearish
- SMA 24N/AN/A
- EMA 6114.59Bearish
- EMA 12136.89Bearish
- EMA 24N/AN/A
- DEMA 698.88Bullish
- DEMA 12N/AN/A
- DEMA 24N/AN/A
- TEMA 699.92Bearish
- TEMA 12N/AN/A
- TEMA 24N/AN/A
- MACDN/AN/A
- ADXN/AN/A
- IndicatorValueSignal
- RSIN/AN/A
- CCIN/AN/A
- ROC 25N/AN/A
- ROC 50N/AN/A
- Stoch KN/AN/A
- Stoch DN/AN/A
- IndicatorValueSignal
- BB Upper280.13Neutral
- BB Middle164.91Neutral
- BB Lower49.70Neutral
- ATR46.50Low Volatility
- IndicatorValueSignal
- MFI49.52Neutral